The DOI matches its Crossref record; 56 of the 60 references it cites were found in a registry or an index.
Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults
Open accessAbstract
Importance: Quadruple misfolded proteins (tau neurofibrillary tangles, amyloid-β [Aβ], α-synuclein, and transactive response DNA-binding protein 43 [TDP-43]) in the same brain are relatively common in aging. However, the clinical presentation, associated factors, frequency in community-based cohorts, genetic characteristics, and cognitive trajectories associated with the quadruple misfolded proteins phenotype are not well understood. Objective: To describe the quadruple misfolded proteins phenotype, including the trajectories of global cognition, in an autopsy cohort. Design, Setting, and Participants: This retrospective cohort study used brain autopsy data from the University of Kentucky Alzheimer Disease Center (UK-ADC) Brain Bank. Participants were deceased individuals who were enrolled in a longitudinal community-based cohort study of aging and dementia in central Kentucky conducted by the UK-ADC. Included participants were enrolled in the UK-ADC cohort between January 1, 1989, and December 31, 2017; aged 55 years or older at baseline; and followed up for a mean duration of 10.4 years. The participants had Alzheimer disease pathology (tau and Aβ), α-synuclein, and TDP-43 data, along with Braak neurofibrillary tangle stage I to VI. Data analysis was conducted between February 1, 2019, and September 30, 2019. Main Outcomes and Measures: Frequency of quadruple misfolded proteins was estimated, and proteinopathy group characteristics and associations with global cognition were evaluated. Multinomial logistic regression was used to estimate the association of proteinopathy group with participant characteristics, including age at death, sex, and apolipoprotein ε4 (APOE ε4) allele. Generalized estimating equations were used to estimate the probability of obtaining Mini-Mental State Examination (MMSE) scores within the normal cognition (27-30 points) and severe impairment (≤13 points) ranges during the 12 years before death. Results: The final sample included 375 individuals (mean [SD] age at death, 86.9 [8.0] years); 232 women [61.9%]). Quadruple misfolded proteins were detected in 41 of 214 individuals with dementia (19.2%). Overall, 46 individuals (12.3%) had quadruple misfolded proteins, whereas 143 individuals (38.1%) had 3 proteinopathies. Dementia frequency was highest among those with quadruple misfolded proteins (41 [89.1%]), and participants with quadruple misfolded proteins had the lowest final mean (SD) MMSE scores of 13.4 (9.8) points. Adjusting for age at death and sex, the APOE ε4 allele was associated with higher odds of quadruple misfolded proteins (adjusted odds ratio, 2.55; 95% CI, 1.16- 5.62; P = .02). The quadruple misfolded proteins group had both the lowest probability of obtaining MMSE scores in the normal cognition range, even 12 years before death, and the highest probability of having MMSE scores in the severe impairment range. Conclusions and Relevance: Quadruple misfolded proteins appear to be a common substrate for cognitive impairment and to be associated with an aggressive course of disease that typically ends with severe dementia. The prevalence of comorbid α-synuclein and TDP-43 with Alzheimer disease pathology (tau and Aβ) may complicate efforts to identify therapies to treat and prevent Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Carriers of the APOEε4 allele have increased odds of a multi-proteinopathy, whereas carrying the APOEε2 allele reduces these odds, relative to APOEε3 homozygosis60,61.”
From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“50–60% of Alzheimer’s-type dementia (dementia defined clinically as Alzheimer’s disease) is estimated to be attributable to these copathologies.40,42–45”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [44]
In the citing paper
“Alzheimer’s disease can be associated with other brain pathologies, including α-synucleinopathy,56 vascular pathology, non-Alzheimer’s disease tauopathies, and TDP-43 pathology.40,42–44”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citationDiagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2024) · doi:10.4135/9781071886229.n145 · Cited by 2,806
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Self-citation
Flagged first, then by citations
4 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 206
Tau in Alzheimer's disease: Shaping the future patient journey
Mummery, C. J., Li-Hsian, C. C., Lasagna‐Reeves, C. A., Ossenkoppele, R., Rowe, C. C., Scharre, D. W., Wang, H., Kyaga, S., & Cummings, J. L. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100447 · Cited by 15
The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins
Panegyres, P. K. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210309 · Cited by 12
α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease
Beatino, M. F., Luca, C. D., Campese, N., Belli, E., Piccarducci, R., Giampietri, L., Martini, C., Perugi, G., Siciliano, G., Ceravolo, R., et al. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2068952 · Cited by 11
Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
Bice, P. J., Nho, K. T., Ertekin‐Taner, N., & Saykin, A. J. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00934-4 · Cited by 14
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer’s disease
Gaetani, L., Chiasserini, D., Paoletti, F. P., Bellomo, G., & Parnetti, L. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2276918 · Cited by 10
Comorbid neuropathology and atypical presentation of Alzheimer's disease
Piña‐Escudero, S. D., Joie, R. L., Spina, S., Hwang, J., Miller, Z., Huang, E. J., Grant, H. E., Mundada, N. S., Boxer, A. L., Gorno‐Tempini, M., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12602 · Cited by 10
New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS
Nelson, P. T. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae113 · Cited by 10
Self-citationShwab, E. K., Pathak, G. A., Harvey, J., Belloy, M. E., Fischer, C. E., Lutz, M. W., Scholz, S. W., Cook, N., Reid, D. M., Chen, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70549 · Cited by 12
Reclassifying neurodegenerative diseases
Villoslada, P., Baeza-Yates, R. A., & Masdeu, J. C. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0600-3 · Cited by 10
Beach, T. G., Serrano, G. E., Driver‐Dunckley, E. D., Sue, L. I., Shill, H. A., Mehta, S. H., Belden, C. M., Lorenzini, I., Tremblay, C., Choudhury, P., et al. (2025) · medRxiv · doi:10.1101/2025.01.13.25319971 · Cited by 10
Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease
Phillips, J. S., Robinson, J. L., Cousins, K. A. Q., Wolk, D. A., Lee, E. B., McMillan, C. T., Trojanowski, J. Q., Grossman, M., & Irwin, D. J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0808-23.2023 · Cited by 9
Genetic associations with dementia‐related proteinopathy: Application of item response theory
Katsumata, Y., Fardo, D. W., Shade, L. M. P., Wu, X., Karanth, S. D., Hohman, T. J., Schneider, J. A., Bennett, D. A., Farfel, J. M., Gauthreaux, K. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13741 · Cited by 8
Self-citationPoulidou, V., Liampas, I., Arnaoutoglou, M., Dardiotis, E., & Siokas, V. (2024) · Biomolecules · doi:10.3390/biom14101213 · Cited by 11
Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD
Chevalier, E., Audrain, M., Ratnam, M., Ollier, R., Fuchs, A., Piorkowska, K., Pfeifer, A., Kosco‐Vilbois, M. H., Seredenina, T. S., & Afroz, T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01867-z · Cited by 10
Liang, J., Li, R., Wong, G., & Huang, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00879-0 · Cited by 13
Di, J., Nelson, R. S., Jicha, G. A., Moga, D. C., Barber, J. M., Cykowski, M. D., Fardo, D. W., Abner, E. L., & Nelson, P. T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230425 · Cited by 8
Self-citationBachstetter, A. D., Lutshumba, J., Winford, E. D., Abner, E. L., Martin, B. J., Harp, J. P., Eldik, L. J. V., Schmitt, F. A., Wilcock, D. M., Stowe, A. M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad259 · Cited by 8
Self-citationKelley, C. M., Maloney, B., Beck, J. S., Ginsberg, S. D., Liang, W. S., Lahiri, D. K., Mufson, E. J., & Counts, S. (2024) · Brain Communications · doi:10.1093/braincomms/fcae082 · Cited by 9
Calderón‐Garcidueñas, L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.901447 · Cited by 9
Rosenberg, G. A. (2022) · Stroke · doi:10.1161/strokeaha.122.039211 · Cited by 9
Studart‐Neto, A., Barbosa, B. J. A. P., Coutinho, A. M., de Souza, L. C., Schilling, L. P., da Silva, M. N. M., Castilhos, R. M., Bertolucci, P. H. F., Borelli, W. V., Gomes, H. R., et al. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-c001 · Cited by 11
Stochasticity, Entropy and Neurodegeneration
Panegyres, P. K. (2022) · Brain Sciences · doi:10.3390/brainsci12020226 · Cited by 8
Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues
Al-Kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Al-Gareeb, A. I., Albuhadily, A. K., Ali, A. A., & Abu-Alghayth, M. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102684 · Cited by 10
Babiloni, C., Noce, G., Bonaventura, C. D., Lizio, R., Eldellaa, A., Tucci, F., Salamone, E. M., Ferri, R., Soricelli, A., Nobili, F. M., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220442 · Cited by 8
Yao, J., Liu, S., & Chen, Q. (2024) · Medicine · doi:10.1097/md.0000000000039816 · Cited by 7
Leone, R., Kobeleva, X., Rowe, B., Choupan, J., Ringman, J. M., & Barisano, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70588 · Cited by 8
Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein
Quint, W. H., Matečko‐Burmann, I., Schilcher, I., Löffler, T., Schöll, M., Burmann, B. M., & Vogels, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201334 · Cited by 7
Mei, F., Hu, J., Wu, Z., Zhang, G., Liu, A., Li, X., Zhu, M., Gan, Y., Liang, L., Zhao, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111101 · Cited by 7
Saunders, C., Rocha-Rangel, P., Desai, R., Quadri, Z., Lui, H., Hunt, J. B., Liang, H., Rogers, C. B., Nash, K. R., Tsoi, P. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.28.639952 · Cited by 7
Self-citationThe Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases
O’Day, D. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413424 · Cited by 6
Neuropathological comorbidity, genetics and cognition in a Chinese community-based autopsy cohort
Wu, W., Wang, X. L., Xu, Y., Ma, C., Qian, X., & Qiu, W. (2025) · Brain · doi:10.1093/brain/awaf039 · Cited by 6
TYK2 as a novel therapeutic target in Alzheimer’s Disease with TDP-43 inclusionsPreprint
König, L. E., Rodriguez, S., Hug, C. B., Daneshvari, S., Chung, A., Bradshaw, G. A., Şahin, A., Zhou, G., Eisert, R. J., Piccioni, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.04.595773 · Cited by 6
Celebrating 40 years of the University of Kentucky Alzheimer's Disease Research Center
Schmitt, F. A., Abner, E. L., Fardo, D. W., Gold, B. T., Jicha, G. A., Kryscio, R. J., Lee, D. C., Nelson, P. T., & Eldik, L. J. V. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70181 · Cited by 7
Self-citationBiological classification of memory clinic patients
Mastenbroek, S. E., Collij, L. E., Anijärv, T. E., Rittmo, J. Ö., Young, A. L., Strandberg, O. T., Smith, R. A., Spotorno, N., Palmqvist, S., Mattsson, N., et al. (2025) · Brain · doi:10.1093/brain/awaf411 · Cited by 7
The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study
Vermeiren, M. R., Somsen, J. F., Luurtsema, G., Reesink, F. E., Verwey, N. A., Hempenius, L., Tolboom, N., Biessels, G. J., Biesbroek, J. M., Vernooij, M. W., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01588-4 · Cited by 5
Crețu, O., Cocu, M., Popescu, E.-R., & Chiriță, R. (2024) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2024.4.08 · Cited by 5
Chen, X., Fang, Z., Zhao, Y., Cheng, W., Chen, H., Li, G., Xu, J., Deng, J., Cai, X., Zhuang, J., et al. (2022) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbac137 · Cited by 4
Associations of potential ADRD plasma biomarkers in cognitively normal volunteers
Estepp, T. G., Charnigo, R. J., Abner, E. L., Jicha, G. A., Sudduth, T. L., Fardo, D. W., & Wilcock, D. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13000 · Cited by 5
Self-citationZhang, X., Chen, Y., Tan, Y., Pan, T., & Wei, G. (2025) · Current Protein and Peptide Science · doi:10.2174/0113892037350729241129054701 · Cited by 6
A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathologyPreprint
Corriveau‐Lecavalier, N., Botha, H., Graff‐Radford, J., Switzer, A. R., Przybelski, S. A., Wiste, H. J., Murray, M. E., Reichard, R. R., Dickson, D. W., Nguyen, A. T., et al. (2023) · medRxiv · doi:10.1101/2023.11.19.23298314 · Cited by 5
Self-citationPlasma proteomics-based brain aging signature and incident dementia risk
Kou, M., Ma, H., Wang, X., Heianza, Y., & Qi, L. (2024) · GeroScience · doi:10.1007/s11357-024-01407-6 · Cited by 5
Higginbotham, L. A., Carter, K., Dammer, E. B., Haque, R. U., Johnson, E. C. B., Duong, D. M., Yin, L., Jager, P. L. D., Bennett, D. A., Lah, J. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.22.501017 · Cited by 4
Beyer, F., Kleine, L., Zülke, A., Luppa, M., Mildner, T., Gensichen, J., Frese, T., Czock, D., Wiese, B., König, H., et al. (2025) · NeuroImage: Clinical · doi:10.1016/j.nicl.2025.103796 · Cited by 2
Dementia with Lewy bodies: a practical guide to clinical diagnosis and management
Fullam, S., Harrison, J. R., Anderson, K. N., Fearon, C., O’Connor, A., Taylor, J., & O’Dowd, S. (2025) · Practical Neurology · doi:10.1136/pn-2025-004745 · Cited by 3
Neuropathological correlates of age and sex differences in 18F-flortaucipir PET
Coomans, E. M., Smith, R. A., Pawlik, D., Hauer, K. O., Palmqvist, S., Stomrud, E., Mattsson, N., Tremblay, C., Serrano, G. E., Beach, T. G., et al. (2026) · Brain · doi:10.1093/brain/awag136 · Cited by 3
Ni, P., Liu, Z., Yang, J. N., Xie, Y., & Wang, S. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s487043 · Cited by 3
Martinez, N., Bharani, K., Hasan, S., & Hayes, C. A. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01863-y · Cited by 3
Li, R., Huang, X., Shen, L., Zhang, T., Liu, N., Hou, X., & Wong, G. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05383-0 · Cited by 3
Qiang, Q., Skudder‐Hill, L., Toyota, T., Huang, Z., Wei, W., & Adachi, H. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.02.008 · Cited by 3
A Precision Medicine Approach to Dementia Care: Syndrome, Etiology, and Copathology.
Fischer, D. L., & Seeley, W. W. (2023) · PubMed · Cited by 3
Cassel, R., Lorenc, F., Bombardier, A., Tapia, C. D., Dieterle, S., Roque, C. G., Jackson, C. A., Stuart‐Lopez, G., Rouaux, C., Guillot, S. J., et al. (2025) · medRxiv · doi:10.1101/2025.06.16.25329673 · Cited by 4
Heumann, J., Cole, S. W., Eisner, M., Ribeaud, D., Grünblatt, E., & Shanahan, M. J. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101025 · Cited by 2
CTE-type tau filaments in Alzheimer’s disease with co-morbid LATE-NC
Rana, J. K., Pinarbasi, E. S., Fernandez, M. G., Navratna, V., Conway, K. S., Lieberman, A. P., Barmada, S. J., & Mosalaganti, S. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03052-z · Cited by 2
Keinänen, X., Vauhkonen, P. K., & Oura, P. (2026) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-026-01195-9 · Cited by 2
Amyloid and Tau Co-pathology in Parkinson Disease and Atypical Parkinsonism
Pinto, M. J. A., Cordero, I. R. G., Dorman, G. S., Mizraji, G., Anastassiadis, C., Gershanik, O. S., & Couto, B. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01488-0 · Cited by 2
Groot, C., Calandri, I. L., Bader, I., Bocancea, D. I., de Bruin, H., Carrigan, M., Collij, L. E., Duits, F. H., Kamps, S., de Koning, L. A., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214810 · Cited by 2
The neural economics of brain aging
Kosyakovsky, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91621-5 · Cited by 3
Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review
Vardheim, E. G., Toft, A. D., Nielsen, J. E., Hasselbalch, S. G., & Simonsen, A. H. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.102438 · Cited by 2
Parkinson disease and air pollution: does what we breathe matter?
Calderón‐Garcidueñas, L. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00531-7 · Cited by 2
Rumo a uma nova era no diagnóstico e tratamento da doença de Alzheimer
Ferrari‐Souza, J. P., & Schilling, L. P. (2023) · PAJAR - Pan-American Journal of Aging Research · doi:10.15448/2357-9641.2023.1.44542 · Cited by 2
Commentary: Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review
Bhagavati, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.895398 · Cited by 2
Dhakal, S., Robang, A. S., Bhatt, N. N., Puangamali, N., Fung, L., Kayed, R., Paravastu, A. K., & Rangachari, V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.14.496041 · Cited by 2
Gawor, K., Tomé, S. O., Vandenberghe, R. R., Damme, P. V., Vandenbulcke, M., Otto, M., Arnim, C. A. F. V., Ghebremedhin, E., Ronisz, A., Ospitalieri, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.599515 · Cited by 2
Shpilyukova, Y. A., Fedotova, E. Y., Kuzmina, E. N., & Illarioshkin, S. N. (2022) · Russian neurological Journal · doi:10.30629/2658-7947-2022-27-2-5-13 · Cited by 1
Biomarkers for Alzheimer's Disease
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Frontal variant of Аlzheimer's disease
Васильевна, Н. К., Shpilyukova, Y. A., Abramycheva, N. Y., Шабалина, А. А., Fedotova, E. Y., & Illarioshkin, S. N. (2025) · Russian neurological Journal · doi:10.30629/2658-7947-2024-29-6-56-63 · Cited by 1
Pathophysiology of Alzheimer’s Disease: Herbal Neurogenesis and Synthetic Molecular Interventions
Kumar, A., Kumar, M., Verma, A., Joshi, R., Bidlan, M., & Singh, R. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00304-2 · Cited by 2
Koo, J., Lee, H. S., Choi, Y. S., Baik, K., Park, M., & Initiative, A. D. N. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1724274 · Cited by 1
Locus coeruleus TDP-43 pathology in a community-based cohort: Clinical and pathological correlates
Neltner, A. M., Shahidehpour, R. K., Hall, M. E., Ning, X., Fister, S. X., Kang, H., Anderson, S., Jicha, G. A., Lee, T., Abner, E. L., et al. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag035 · Cited by 1
Self-citationAtrophy signature for alpha‐synuclein copathology in Alzheimer's disease
Esteller, D., Guillén, N., Falgàs, N., Bosch, B., Tort‐Merino, A., Borrego‐Écija, S., Puey, R., Ruiz‐García, R., Naranjo, L., Niñerola‐Baizán, A., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70347 · Cited by 1
Donley, G. M., Hsiao, J., Balintfy, J., & Silverberg, N. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71511 · Cited by 1
Neuropathology in a diverse cohort of oldest‐old: The LifeAfter90 study
Dugger, B. N., Luu, M. N., Patel, V., DeCarli, C. S., Jin, L., Gilsanz, P., Mungas, D., Kawas, C. H., Corrada, M. M., & Whitmer, R. A. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71634 · Cited by 1
Desai, R., Lee, D. C., & Selenica, M. B. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167991 · Cited by 1
The future of dementia prevention and treatment strategies
直行, 里. (2020) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.57.374 · Cited by 1
Diagnosis of Dementia with Lewy Bodies: Fluctuations, Biomarkers, and Beyond
Olichney, J., Li, W., Gharbaoui, Y., Kwok, A. P., & Jenkins, J. E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98433 · Cited by 1
Shade, L. M. P., Katsumata, Y., Claas, S. A., Ebbert, M., Abner, E. L., Hohman, T. J., Mukherjee, S., Nho, K. T., Saykin, A. J., Bennett, D. A., et al. (2022) · medRxiv · doi:10.1101/2022.12.13.22282475 · Cited by 1
Self-citationBeyer, F., Kleine, L., Zülke, A. E., Luppa, M., Mildner, T., Frese, T., Gensichen, J. S., Czock, D., Wiese, B., König, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5303457/v1 · Cited by 1
Turk, K. W., Geada, A., Alvarez, V. E., Xia, W., Cherry, J. D., Nicks, R., Meng, G., Daley, S. A., Tripodis, Y., Huber, B. R., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.051392
Biomarkers in cerebrospinal fluid and blood aid diagnosis of dementia
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00001-8
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00006-7
Clinical aspects of diagnosis in dementia
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00009-2
Classification of subtypes of vascular dementia
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00010-9
Appropriate Use of Biomarkers in Suspected Neurodegenerative Diseases
Lamotte, G. J., & Foster, N. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_2
Uemura, M. T. (2024) · Journal of The Society of Japanese Women Scientists · doi:10.5939/sjws.240005
Restrepo-Martínez, M., Ruiz‐Garcia, R., Houpt, J. A., Ang, L. C., Chaudhari, S., & Finger, E. C. (2024) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000379
Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers
Naiyeri, A., Moqadami, A., & Khalaj‐Kondori, M. (2025) · Current Gene Therapy · doi:10.2174/0115665232338503241227111640
Ashford, J. W. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241313398
Brain and Antiaging Medicine: Age-Related Changes in Cognitive Function
Sato, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-8514-8_36
Huang, Y., Shang, L., Li, B., Wang, T., Zhang, X., Wei, J., Mao, C., & Gao, J. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf006
Characterizing individuals fulfilling clinical criteria for LATE in a tertiary memory clinicPreprint
Groot, C., Calandri, I. L., Bader, I., Bocancea, D. I., de Bruin, H., Carrigan, M., Collij, L. E., Duits, F., Kamps, S., de Koning, L. A., et al. (2025) · medRxiv · doi:10.1101/2025.10.22.25338577
Cognitive Disorders of the Very Old: From Clinic to Pathology
Valcour, V., & Grinberg, L. T. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.015
Agrawal, S., Yu, L., Nag, S., Arfanakis, K., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2021) · Figshare · doi:10.6084/m9.figshare.16681456
Liu, A. Y.-C., Kwan, K. Y., Kwan, C., & Chen, K. Y. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00966
Negro, G., Poloni, C., Medici, V., Calatozzolo, C., Canazza, A., Ferrari, R. R., Cutaia, C., Davin, A., & Poloni, T. E. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1774283
TYK2 mediates neuroinflammation in Alzheimer’s disease brains with TDP-43 pathology
König, L. E., Rodriguez, S., Hug, C. B., Daneshvari, S., Chung, A., Appleman, M., Tsai, M., Bradshaw, G. A., Şahin, A., Song, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70243-3 · Cited by 7
The brainstem in neurodegenerative diseases
Grinberg, L. T. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-15736-3.00017-2
Dautricourt, S. (2021) · theses.fr (ABES) · doi:10.70675/63472a25z31eaz4ebczaebdzd8d2e061b4b8
Wu, L., Akingbade, T. O., Nelson, P. T., Wang, S. J., & Xu, B. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03027-0
Self-citationThe Promise and Peril of Alzheimer Disease Prevention
Grill, J. D., & Graff‐Radford, J. (2026) · Neurology · doi:10.1212/wnl.0000000000218348
Kou, X., Hu, Q., Kou, Y., & An, D. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1814795
Metadata
- Authors
- Karanth, S., Nelson, P. T., Katsumata, Y., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Cykowski, M. D., Jicha, G. A., Van Eldik, L. J., & Abner, E. L.
- Affiliations
- University of Kentucky (US)
- Houston Methodist (US)
- Sanders-Brown Center on Aging, University of Kentucky, Lexington
- Corresponding author
- Abner, Erin L.
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2020-10-01
- Volume
- 77
- Issue
- 10
- Pages
- 1299
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC7309572
- OpenAlex
- W3035869254
- Cited by
- 206
- References
- 60
- Citations by year
- 2026: 25 · 2025: 33 · 2024: 46 · 2023: 33 · 2022: 38 · 2021: 24 · 2020: 7
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Eisai
- National Institutes of Health (5r01ag038651-10)
- National Institute on Aging (AG-028383, R01‐AG038651, P30AG028383, P01AG003949, R56AG057191, P30AG072946)
- National Heart, Lung, and Blood Institute
- National Institute on Drug Abuse
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- neurofibrillary tangles, amyloid-beta, alpha-synuclein, TDP-43, proteinopathies, dementia, Alzheimer's disease, cognitive trajectories, APOE ε4, older adults, autopsy brain tissue, clinical phenotype, central Kentucky
- MeSH terms
- Aged, Aged, 80 and over, DNA-Binding Proteins, Female, Follow-Up Studies, Humans, Male, Phenotype, Retrospective Studies, Cohort Studies, Prevalence, Amyloid beta-Peptides, Neurofibrillary Tangles, tau Proteins, alpha-Synuclein, Proteostasis Deficiencies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
